about
Alpha-lipoic acid for diabetic peripheral neuropathyScoring systems to screen for diabetic peripheral neuropathySimple tests to screen for diabetic peripheral neuropathyImmunotherapy for diabetic amyotrophyAlpha-lipoic acid for diabetic peripheral neuropathyBlocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.Local regulation of fat metabolism in peripheral nerves.Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells.Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy.Characterizing the cytoprotective activity of Sarracenia purpurea L., a medicinal plant that inhibits glucotoxicity in PC12 cells.Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy.Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.Diabetes mellitus and its chronic complications.The impact of low-dose insulin on peripheral nerve insulin receptor signaling in streptozotocin-induced diabetic rats.Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediatorsC-peptide and diabetic neuropathy.Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.Early diabetic neuropathy: triggers and mechanisms.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Tang-Tong-Fang Confers Protection against Experimental Diabetic Peripheral Neuropathy by Reducing Inflammation.Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.Effects of axonal ion channel dysfunction on quality of life in type 2 diabetesEffect of C-peptide on diabetic neuropathy in patients with type 1 diabetesEffects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.Fuzi attenuates diabetic neuropathy in rats and protects schwann cells from apoptosis induced by high glucose.Cilostazol in diabetic neuropathy: premature farewell or new beginning?Neuropathy in prediabetes: does the clock start ticking early?Diabetic peripheral neuropathy: role of reactive oxygen and nitrogen species.Immunotherapy for diabetic amyotrophy.Date fruit extract is a neuroprotective agent in diabetic peripheral neuropathy in streptozotocin-induced diabetic rats: a multimodal analysisDiabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats.Two-stage community-based screening model for estimating prevalence of diabetic polyneuropathy (KCIS no. 6).Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.Insulin implants prevent the temporal development of mechanical allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats.The stem bark extracts of Cenostigma macrophyllum attenuates tactile allodynia in streptozotocin-induced diabetic rats.Nerve growth factor blocks the glucose-induced down-regulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling.Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.
P2860
Q24187870-4BCB3D5D-FDDB-42D7-A05D-BC3EFC8DD50DQ24198177-C9AE318F-276E-45D2-8C84-0F6ACA9CED70Q24200655-E48CACD1-4E9A-43D6-BAA6-EFA61249BCBAQ24202710-77052732-A236-4FDD-8128-05F68800F112Q24246065-22957126-95D5-4BEF-9DA3-47F4FED2F04EQ27330087-C8AE362B-88BD-45FA-86EF-E04EF0D6BF57Q28510849-80A0D179-A816-4EC0-9AB5-86FC48EB41F5Q33593046-C76A8DCF-DF76-4663-ADCE-21CBEF42F03FQ34097615-5F6F6DCF-F7D8-45D5-983F-4F0C4BAAF53FQ34218901-DA5CC83A-5E22-4554-AA99-AE54EDC1707CQ34502216-FED6C71C-0798-4F70-B7FA-2E0246A1E840Q34626341-3848225C-58D3-42C2-BCEF-D115D3CC7916Q34733625-E91C4107-60FF-4040-8A78-CDCCAD529BD4Q34795600-B020E41C-A4DD-4D90-B134-8F435F9DF7B6Q34983794-C2804136-41D0-43C5-A217-4AE87507D384Q35063229-B21B508F-89DE-4417-8D50-FBFAF5079C13Q35168721-FAF9D308-8649-4F89-82D4-A13B4B3033EAQ35207611-BB9E9370-8737-4F3B-85F4-5393379DDA2DQ35687048-8945E68F-0AA9-4777-88A9-69D5E36ABEE0Q35691425-E70CF6A1-7D47-4BB9-A967-F7B44E2CD897Q35896615-95DB5652-26A0-4E32-80ED-CC243DC8351DQ36204351-A089B2C0-8FC4-4070-97E7-EEDB9E2E8CE7Q36509492-A47B8A42-2EEE-4A11-8492-0C41B2E6766EQ36782662-33CD9C46-1CBE-459A-B044-129FDAFFBB10Q37113466-2440B8F7-F32A-48DB-A74D-2E1320D2B488Q37227426-21D8FADD-F43E-4019-A356-90FC2B9DE7F8Q37510236-BBC746AB-0BA5-42F9-B9F8-8EAE198F54DBQ37867839-45591BF8-4895-47C8-BE0B-AE71BB4F3A29Q37900473-78B3DE1D-B7C4-476D-8B91-1014176DF6C2Q38110740-0D49F51D-715D-4AA8-A79C-E229537C276BQ38659950-EE8A22A9-9E7B-4A77-920F-54B2190802E8Q39751029-FF0CC1A3-82C4-4916-B9BB-0526F11B112FQ40756119-79D1611B-5F2F-43D2-ABF4-F09B2D764855Q43049705-4DC1E1B0-0754-41BA-9B70-4EC23E3FAE81Q44174028-4B7D6C76-F558-407C-B490-3016614C18D1Q44240871-2A2F40AA-C09E-436C-B6E0-A08C8BB8CAA0Q44350262-0871052C-8415-4729-8D8B-AB0752B68580Q44364773-ED88E370-3B62-40DE-9EF1-51D68E13C2D3Q44392748-2967C7E0-3864-43D6-9AEC-CCBCFCF2D0E4Q44538902-1453C204-A561-4522-8937-40BBEF610AAD
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Diabetic neuropathy--a continuing enigma.
@ast
Diabetic neuropathy--a continuing enigma.
@en
Diabetic neuropathy--a continuing enigma.
@nl
type
label
Diabetic neuropathy--a continuing enigma.
@ast
Diabetic neuropathy--a continuing enigma.
@en
Diabetic neuropathy--a continuing enigma.
@nl
prefLabel
Diabetic neuropathy--a continuing enigma.
@ast
Diabetic neuropathy--a continuing enigma.
@en
Diabetic neuropathy--a continuing enigma.
@nl
P2093
P2860
P1476
Diabetic neuropathy--a continuing enigma.
@en
P2093
P2860
P304
P356
10.1002/1520-7560(200011/12)16:6<408::AID-DMRR158>3.0.CO;2-R
P577
2000-11-01T00:00:00Z